Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.

In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomasz Janek, Anna Krasowska, Agata Radwańska, Marcin Łukaszewicz
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a517c7331e204bd79a4a62d3101eb19a
record_format dspace
spelling oai:doaj.org-article:a517c7331e204bd79a4a62d3101eb19a2021-11-18T07:54:38ZLipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.1932-620310.1371/journal.pone.0057991https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23483962/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca(2+) influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent.Tomasz JanekAnna KrasowskaAgata RadwańskaMarcin ŁukaszewiczPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e57991 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tomasz Janek
Anna Krasowska
Agata Radwańska
Marcin Łukaszewicz
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
description In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca(2+) influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent.
format article
author Tomasz Janek
Anna Krasowska
Agata Radwańska
Marcin Łukaszewicz
author_facet Tomasz Janek
Anna Krasowska
Agata Radwańska
Marcin Łukaszewicz
author_sort Tomasz Janek
title Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
title_short Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
title_full Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
title_fullStr Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
title_full_unstemmed Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
title_sort lipopeptide biosurfactant pseudofactin ii induced apoptosis of melanoma a 375 cells by specific interaction with the plasma membrane.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a
work_keys_str_mv AT tomaszjanek lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane
AT annakrasowska lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane
AT agataradwanska lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane
AT marcinłukaszewicz lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane
_version_ 1718422792130527232